Dr. Xiyuan Bai is a molecular microbiologist/biochemist and Associate Professor of Medical Research in the Department of Medicine at the University of Colorado School of Medicine and Research Fellow at the Denver VA Medical center and National Jewish Health. He received his Ph.D. in the Institute of Molecular Microbiology and Biotechnology from Westfaelische Wilhelms-University of Muenster, Germany. He did his postdoctoral training at Institute of Genetic, Biochemistry and Microbiology of University of Nuerberg-Erlangeng, Germany, and at McLaughlin Research Institute for Biomedical Science Great Falls, Montana. His area of expertise is cellular and molecular biology, basic immunology and inflammation, animal modeling (gene knockout/in, CRISPR), respiratory bacterial infections, and bioinformatics.
His research interests include new drug from nature substance and molecule against TB, molecular pathogenesis of pulmonary infectious disease-Mycobacterium tuberculosis (MTB) and Nontuberculosis mycobacteria (NTM), host-pathogen interaction in the field of signal transduction, immunology, gene expression and regulation, Animal modeling study of drug discovering in human pulmonary infectious disease, TB Vaccine.